Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata

被引：0

作者：

Shapiro, Jerry ^{[1
]}

Ko, Justin ^{[2
]}

Egeberg, Alexander ^{[3
]}

Somani, Najwa ^{[4
]}

Jedynak, Jakub ^{[4
]}

Torisu-Itakura, Hitoe ^{[4
]}

Yu, Guanglei ^{[4
]}

Lu, Na ^{[5
]}

Craiglow, Brittany ^{[6
]}

机构：

[1] New York Univ, Grossman Sch Med, New York, NY USA

[2] Stanford Med, Stanford, CA USA

[3] Copenhagen Univ Hosp Bispebjerg, Copenhagen, Denmark

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Precis Stat Consulting, Woodbury, MN USA

[6] Yale Sch Med, New Haven, CT USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

41247

引用

页码：AB127 / AB127

页数：1

共 50 条

[21] Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
King, Brett
Ohyama, Manabu
Mostaghimi, Arash
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB33 - AB33
[22] Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
Senna, Maryanne
Forman, Seth
Bordone, Lindsey
De La Cueva Dobao, Pablo
Wolk, Robert
Zwillich, Samuel
Zhang, Fan
Ahmed, Haytham Mohamed
Takiya, Liza
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB221 - AB221
[23] SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
Olsen, Elise A.
Canfield, Douglas
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (06) : 1268 - 1270
[24] The relationship between the degree of scalp hair loss and health-related quality of life among patients with alopecia areata
Edson-Heredia, Emily
Cutts, Katelyn
Bethesda, Evidera
Wright, Peter
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB120 - AB120
[25] Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss
Tobin, DJ
Sundberg, JP
King, LE
Boggess, D
Bystryn, JC
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 329 - 333
[26] Concordance between clinician- reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVEAA1 and BRAVE-AA2 studies
Mostaghimi, Arash
Ko, Justin
Tosti, Antonella
McMichael, Amy
Ohyama, Manabu
Ito, Taisuke
Dutronc, Yves
Ball, Susan
Yu, Guanglei
Murage, Mwangi
Chen, Yun-Fei
Chiasserini, Chiara
Wollenberg, Andreas
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 729 - 732
[27] Impaired autophagy promotes hair loss in the C3H/HeJ mouse model of alopecia areata
Gund, Rupali
Christiano, Angela M.
AUTOPHAGY, 2023, 19 (01) : 296 - 305
[28] 723-Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
Tziotzios, Christos
Sinclair, Rodney
Lesiak, Aleksandra
Mehlis, Stephanie
Kinoshita-Ise, Misaki
Tsianakas, Athanasios
Luo, Xin
Law, Ernest H.
Wolk, Robert
Sadrarhami, Mojgan
Lejeune, Alexandre
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[29] Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Thaci, Diamant
Tziotzios, Christos
Ito, Taisuke
Ko, Justin
Karadag, Ayse Serap
Fang, Hong
Edwards, Roger A.
Bonfanti, Gianluca
Wolk, Robert
Tran, Helen
Law, Ernest
DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2621 - 2634
[30] Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Thaci, Diamant
Tziotzios, Christos
Ito, Taisuke
Ko, Justin
Karadag, Ayse Serap
Fang, Hong
Edwards, Roger A.
Bonfanti, Gianluca
Wolk, Robert
Tran, Helen
Law, Ernest
DERMATOLOGY AND THERAPY, 2023, : 2621 - 2634

← 1 2 3 4 5 →